New Diffblue Testing Agent Automatically Generates Comprehensive Regression Test Suites To Derisk Application Modernization ...

An interview with Joshua Reuss, MD, thoracic medical oncologist at Georgetown University and co-author of the guidelines. For clinicians managing patients with advanced non–small cell lung cancer ...

I test a lot of coffee machines. Like, a lot of them. The Ratio Four is the small-batch brewer I use to try new kinds of coffee. Coffee is the original office biohack and the nation’s most popular ...

Survival outcomes of patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) receiving lutetium Lu 177 vipivotide tetraxetan (Lu) by prior taxane exposure. Overall survival (OS) in ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

LITTLE ROCK, Ark. (KATV) — It’s a question so many women have asked: "If my mother had breast cancer, will I get it too?" But doctors say knowledge is power, and that power could save your life. UAMS ...

MOBSTA is a robustness testing tool for ROS that tests autonomous systems under realistic but rare conditions that are not represented in training data and difficult to replicate during field testing.

NOTCH1 mutations, found in 20% of CLL cases, are associated with poor outcomes in chemotherapy but not yet in treatment guidelines. A retrospective analysis showed improved PFS for NOTCH1-mutated CLL ...

Insurance covers some genetic tests, such as BRCA tests for breast cancer, if you meet certain requirements. Find Cheap Health Insurance Quotes in Your Area But there are about 70,000 different ...

ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma A total of ...